MX2019003288A - Proteínas de mycobacterium tuberculosis en pruebas diagnósticas y dispositivos para la detección y diagnóstico de la tuberculosis. - Google Patents
Proteínas de mycobacterium tuberculosis en pruebas diagnósticas y dispositivos para la detección y diagnóstico de la tuberculosis.Info
- Publication number
- MX2019003288A MX2019003288A MX2019003288A MX2019003288A MX2019003288A MX 2019003288 A MX2019003288 A MX 2019003288A MX 2019003288 A MX2019003288 A MX 2019003288A MX 2019003288 A MX2019003288 A MX 2019003288A MX 2019003288 A MX2019003288 A MX 2019003288A
- Authority
- MX
- Mexico
- Prior art keywords
- tuberculosis
- diagnosis
- devices
- mycobacterium tuberculosis
- diagnostic assays
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/5695—Mycobacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1289—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Mycobacteriaceae (F)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G01N33/505—Cells of the immune system involving T-cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
- G01N33/538—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by sorbent column, particles or resin strip, i.e. sorbent materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
- G01N33/6866—Interferon
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/555—Interferons [IFN]
- G01N2333/57—IFN-gamma
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente invención proporciona un método para detectar los anticuerpos en una muestra proveniente de un sujeto, en donde los anticuerpos se unen a epítopes mediante antígenos de Mycobacterium tuberculosis, que comprende poner en contacto la muestra con dos o más polipéptidos aislados o fragmentos antigénicos o variantes de los mismos, en donde los polipéptidos comprenden polipéptidos seleccionados del grupo que consiste de las SEQ ID NOS: 1, 3, 5, 7, 9, 11, 13, y 15; y detectar la formación de complejos de anticuerpos-péptidos que comprende los polipéptidos aislado o los fragmentos antigénicos o variantes de los mismos, en donde la formación de los complejos es indicativa de la presencia de los anticuerpos para los epítopes de los antígenos de Mycobacterium tuberculosis en la muestra.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662398213P | 2016-09-22 | 2016-09-22 | |
PCT/US2017/063154 WO2018068064A2 (en) | 2016-09-22 | 2017-11-22 | Mycobacterium tuberculosis proteins in diagnostic assays and devices for tuberculosis detection and diagnosis |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2019003288A true MX2019003288A (es) | 2019-11-05 |
Family
ID=61831255
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2019003288A MX2019003288A (es) | 2016-09-22 | 2017-11-22 | Proteínas de mycobacterium tuberculosis en pruebas diagnósticas y dispositivos para la detección y diagnóstico de la tuberculosis. |
Country Status (7)
Country | Link |
---|---|
US (1) | US20190293645A1 (es) |
EP (2) | EP4257976A3 (es) |
CN (1) | CN110073215B (es) |
BR (1) | BR112019005732A2 (es) |
CA (1) | CA3059408A1 (es) |
MX (1) | MX2019003288A (es) |
WO (1) | WO2018068064A2 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113740529B (zh) * | 2021-08-25 | 2023-05-26 | 华中农业大学 | 一种犬吉氏巴贝斯虫抗体乳胶凝集检测试剂盒及其制备方法和应用 |
WO2023028565A1 (en) * | 2021-08-25 | 2023-03-02 | Moon, Sung Woo | Lateral flow assay by using carboxyl latex beads and biotin-polystreptavidin for the detection of covid-19 infection and diagnostic kit using the lateral flow assay |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2378051T3 (es) * | 1995-09-01 | 2012-04-04 | Corixa Corporation | Compuestos y métodos para el diagnóstico de la tubercolosis. |
US6458366B1 (en) * | 1995-09-01 | 2002-10-01 | Corixa Corporation | Compounds and methods for diagnosis of tuberculosis |
GB9624456D0 (en) | 1996-11-25 | 1997-01-15 | Isis Innovation | Assay method |
US6982085B2 (en) * | 1997-04-02 | 2006-01-03 | Statens Serum Institut | TB diagnostic based on antigens from M. tuberculosis |
US6291190B1 (en) * | 1998-08-25 | 2001-09-18 | The Board Of Trustees Of The Leland Stanford Junior University | Molecular differences between species of the M. tuberculosis complex |
ES2364520T3 (es) * | 1998-08-25 | 2011-09-06 | The Board Of Trustees Of The Leland Stanford Junior University | Marco de lectura abierto rv2660c de m. tuberculosis y su utilización. |
US20040018574A1 (en) * | 1998-08-25 | 2004-01-29 | Marcel Behr | Molecular differences between species of the M. tuberculosis complex |
CN1277843C (zh) * | 2001-02-22 | 2006-10-04 | 巴斯德研究院 | 分枝杆菌比较基因组学作为鉴定分枝杆菌病的诊断、预防或治疗靶的工具 |
US20060046310A1 (en) | 2004-08-25 | 2006-03-02 | Zong-Li Xia | Amplification method for solid phase immunoassays |
BRPI0708865A8 (pt) * | 2006-03-14 | 2019-01-22 | Univ Oregon Health & Science | métodos para produzir uma resposta imune à tuberculose |
US7776341B2 (en) * | 2006-08-10 | 2010-08-17 | Colorado State University Research Foundation | Biomarkers of tuberculosis that distinguish disease categories: use as serodiagnostic antigens |
US7776618B2 (en) | 2007-03-01 | 2010-08-17 | Church & Dwight Co., Inc. | Diagnostic detection device |
CN102718848A (zh) * | 2012-06-01 | 2012-10-10 | 上海交通大学 | 结核分枝杆菌Rv3120的重组蛋白、其制备方法及其在细胞免疫诊断中的应用 |
-
2017
- 2017-11-22 MX MX2019003288A patent/MX2019003288A/es unknown
- 2017-11-22 WO PCT/US2017/063154 patent/WO2018068064A2/en active Application Filing
- 2017-11-22 CA CA3059408A patent/CA3059408A1/en active Pending
- 2017-11-22 EP EP23180076.4A patent/EP4257976A3/en active Pending
- 2017-11-22 US US16/336,022 patent/US20190293645A1/en active Pending
- 2017-11-22 CN CN201780072214.1A patent/CN110073215B/zh active Active
- 2017-11-22 EP EP17859333.1A patent/EP3516394B1/en active Active
- 2017-11-22 BR BR112019005732A patent/BR112019005732A2/pt unknown
Also Published As
Publication number | Publication date |
---|---|
WO2018068064A3 (en) | 2018-06-28 |
WO2018068064A9 (en) | 2018-05-31 |
CN110073215A (zh) | 2019-07-30 |
BR112019005732A2 (pt) | 2019-08-06 |
WO2018068064A2 (en) | 2018-04-12 |
EP4257976A2 (en) | 2023-10-11 |
EP3516394C0 (en) | 2023-06-21 |
CA3059408A1 (en) | 2018-04-12 |
CN110073215B (zh) | 2024-04-30 |
EP4257976A3 (en) | 2024-01-24 |
EP3516394B1 (en) | 2023-06-21 |
EP3516394A2 (en) | 2019-07-31 |
EP3516394A4 (en) | 2020-09-02 |
US20190293645A1 (en) | 2019-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2019283892A1 (en) | Anti-human papillomavirus 16 E7 T cell receptors | |
BR112018070823A2 (pt) | anticorpo sirpa anti-humano ou fragmento de ligação a antígeno do mesmo ou mimético de anticorpo de ligação a antígeno, composição farmacêutica, produto de combinação, molécula de ácido nucleico isolada, vetor, célula hospedeira isolada, polipeptídeo, métodos para fabricar um anticorpo, in vitro ou ex vivo para determinar células positivas para sirpa, de diagnóstico e para prever a resposta de um sujeito, e, uso de um anticorpo anti-sirpa ou um fragmento de ligação a antígeno do mesmo ou um mimético de ligação a anticorpo e in vitro ou ex vivo de pelo menos um anticorpo sirpa anti-humano ou fragmento de ligação a antígeno do mesmo ou mimético de anticorpo de ligação a antígeno. | |
JP2018042573A5 (es) | ||
BR112017001818A2 (pt) | receptores antigênicos quiméricos específicos para egfrviii para imunoterapia de câncer | |
SG10201906750XA (en) | Assays for detecting the presence or amount of an anti-drug antibody | |
AR098126A1 (es) | Anticuerpos anti-ly6e (locus e del complejo del antígeno 6 linfocítico), inmunoconjugados y métodos para usarlos | |
JP2016029056A5 (es) | ||
JO3812B1 (ar) | أجسام مضادة ترتبط بالمركب الترابطي البشري للموت المبرمج 1 (pd-l1) | |
MX2013014961A (es) | Variantes anticuerpos y usos de las mismas. | |
JP2015533788A5 (es) | ||
MX2015012824A (es) | Antigenos recombinantes ns3 del vhc y mutantes de los mismos para la deteccion mejorada de anticuerpos. | |
MX353464B (es) | Antigenos tpn47 de treponema pallidum, inmunoreactivos, solubles. | |
WO2015112558A3 (en) | Peptides, devices, and methods for the detection of anaplasma antibodies | |
JP2017502253A5 (es) | ||
MX2019002178A (es) | Peptidos de fusion con antigenos enlazados a fragmentos cortos de cadena invariante (cd74). | |
MX2019003288A (es) | Proteínas de mycobacterium tuberculosis en pruebas diagnósticas y dispositivos para la detección y diagnóstico de la tuberculosis. | |
BR112016019739A2 (pt) | novo anticorpo de anti-presepsina | |
WO2018085431A8 (en) | Filamin a binding proteins and uses thereof | |
BR112018073660A2 (pt) | anticorpos anti-fator ix pádua | |
Ronholm et al. | Monoclonal antibodies recognizing the surface autolysin IspC of Listeria monocytogenes serotype 4b: epitope localization, kinetic characterization, and cross-reaction studies | |
JP2015529211A5 (es) | ||
JP2017524689A5 (es) | ||
WO2015128394A3 (en) | Soluble and immunoreactive variants of htlv capsid antigen p24 | |
MX2017005156A (es) | Metodo para determinacion de anticuerpos de anti-farmaco contra anticuerpo de farmaco humano o humanizado de funcion efectora suprimida. | |
NZ700199A (en) | Epsilon toxin epitopes from clostridium perfringens with reduced toxicity |